In addition , GI reactions such as symptoms related to meals and type of stools significantly improved only in patients treated with Lact.reuteri , while severity and frequency of cutaneous symptoms ( urticaria , itch and eczema ) and recurrent abdominal pain ( RAP ) as well as VAS scores statistically decreased in both groups .